Philip N. Sussman

Perosphere, Inc. operates as a pharmaceutical company that focuses on addressing unmet medical needs associated with anticoagulant therapies. Its drug product candidate, ciraparantag, is an intravenously administered small synthetic water soluble new molecular entity rationally designed for use as a broad-spectrum reversal agent for anticoagulants including heparins and the new oral anticoagulants allowing rapid re-establishment of a normal blood coagulation state when clinically indicated. The firm's device product candidate is point-of-care coagulometer, a hand-held device that tests fresh or citrated whole blood. The system is designed for broad-spectrum monitoring of the activity of anticoagulants and their corresponding antidotes, across drug classes, in a hospital setting at a patient's bedside. The company was founded by Sasha H. Bakhru, Edith Mathiowitz, Bryan E. Laulicht and Solomon S. Steiner in 2011 and is headquartered in Danbury, CT.

Perosphere, Inc. operates as a pharmaceutical company that focuses on addressing unmet medical needs associated with anticoagulant therapies. Its drug product candidate, ciraparantag, is an intravenously administered small synthetic water soluble new molecular entity rationally designed for use as a broad-spectrum reversal agent for anticoagulants including heparins and the new oral anticoagulants allowing rapid re-establishment of a normal blood coagulation state when clinically indicated. The firm's device product candidate is point-of-care coagulometer, a hand-held device that tests fresh or citrated whole blood. The system is designed for broad-spectrum monitoring of the activity of anticoagulants and their corresponding antidotes, across drug classes, in a hospital setting at a patient's bedside. The company was founded by Sasha H. Bakhru, Edith Mathiowitz, Bryan E. Laulicht and Solomon S. Steiner in 2011 and is headquartered in Danbury, CT.

Thar Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The firm focuses on transforming intravenous drugs into oral drugs for existing and new indications. The company was founded by Mazen Hanna and Raymond K. Houck and is headquartered in Pittsburgh, PA.

Lesanne Life Sciences LLC operates as a stroke diagnostics company. The firm develops diagnostics foe the stroke, traumatic brain injury and CNS ischemia from CABG surgery. The company was founded by Ann H. Cornell-Bell, Leslie A. Riblet, Robert J. Beckman, Allan R. Goldberg and Philip N. Susman in 2006 and is headquartered in Ivoryton, CT.

Lesanne Life Sciences LLC operates as a stroke diagnostics company. The firm develops diagnostics foe the stroke, traumatic brain injury and CNS ischemia from CABG surgery. The company was founded by Ann H. Cornell-Bell, Leslie A. Riblet, Robert J. Beckman, Allan R. Goldberg and Philip N. Susman in 2006 and is headquartered in Ivoryton, CT.